Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient

Nephrology Dialysis Transplantation

Volumn 14, Issue 10, 1999, Pages 2489-2491

  Grimbert, Philippe ^a   Azema, Christine ^a   Pastural, Myriam ^a   Dhamane, Djamel ^a   Remy, Philippe ^a   Salomon, Laurent ^a   Schortgen, Fredérique ^a   Baron, Christophe ^a   Lang, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

Neurological complications; Renal transplantation; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; ARTICLE; BRAIN DISEASE; CASE REPORT; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

BRAIN DISEASES; EPILEPSY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; STATUS EPILEPTICUS; TACROLIMUS;

EID: 0032860809     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.10.2489     Document Type: Article

References (10)

1. Eidelman BH, Abu-Elmagd K, Wilson J et al. Neurologic complications of FK 506. Transplant Proc 1991; 23: 3175-3178
2. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110-1115
3. Appignani B, Bhadelia R, Blacklow S, Wang A, Roland S, Freeman R. Neuroimaging findings in patients on immuno-suppressive therapy: experience with tacrolimus toxicity. Am J Roentgenol 1996; 166: 683-688
4. Pirsch JD, Miller J, Deierhoi M, Vicenti F, Filo R. A comparison of tacrolimus and cyclosporin for immunosuppression after cadaveric renal transplantation. Transplantation 1997; 63: 977-983
5. Small L, Fukui M, Branblett G, Eidelman B. Immunosupression-induced leucoencephalopathy from tacrolimus. Ann Neurol 1996; 40: 575-580
6. Thyagarajan G, Cobanoglu A, Johnston W. FK506-induced fulminant leukoencephalopathy after single-lung transplantation. Ann Thorac Surg 1997; 64: 1461-1464
7. Mueller AR, Platz KP, Bechstein WO et al. Neurotoxicity after orthotopic liver transplantation. Transplantation 1994; 58: 155-170
8. De Groen PC, Aksamit AJ, Rakela J, Forbes GS, Krom RAF. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. N Engl J Med 1987; 317: 861-866
9. Shutter LA, Green JP, Newman NJ, Hooks MA, Gordon RD. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation Neurology 1993; 43: 2417-2418
10. Reyes J, Gayowski T, Fung J, Todo S, Alessiani M, Starzl TE. Expressive dysphasia, possibly related to FK506 in two liver transplant recipients. Transplantation. 1990; 50: 1043-1045